Coming Soon: The First mRNA Vaccine for Melanoma?
Results of a phase 2b trial were favorable, and Moderna suggests that an mRNA vaccine for melanoma could be available in 2025.
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results of a phase 2b trial were favorable, and Moderna suggests that an mRNA vaccine for melanoma could be available in 2025.
Transcranial alternating current stimulation reduces insomnia severity, increases total sleep time, and alleviates daily disturbances such as fatigue.
Phase 2b study data also showed a dose reduction in glucocorticoids among those who received the investigational drug compared with patients who received placebo.
New findings support starting tecovirimat treatment at the time of suspected mpox diagnosis in all people with HIV.
Novo Nordisk's CEO said on Tuesday he expects patients will stick with the company's popular obesity drug Wegovy for far longer than those using older...